视网膜疾病中干细胞因子/c-KIT与半乳糖凝集素-1的眼内浓度
研究比较了干性年龄相关性黄斑变性(AMD)、新生血管性AMD(nAMD)、糖尿病黄斑水肿(DME)、视网膜静脉阻塞(RVO)患者与白内障正常对照者房水中干细胞因子(SCF)、c-KIT、半乳糖凝集素-1(GAL-1)和血管内皮生长因子(VEGF)-A的浓度。结果显示nAMD、DME和RVO眼内SCF、c-KIT和GAL-1水平较对照升高,nAMD中三者与VEGF-A正相关;抗VEGF治疗后GAL-1和VEGF-A显著下降而SCF和c-KIT无显著变化。
要点
- nAMD、DME和RVO患者房水中SCF、c-KIT和GAL-1水平较白内障对照升高。
- nAMD眼内三种细胞因子水平均与VEGF-A水平呈正相关。
- 抗VEGF治疗后GAL-1和VEGF-A显著下降,SCF和c-KIT无显著变化。
核心结论
- nAMD、DME和RVO眼内SCF、c-KIT和GAL-1水平较对照显著升高,且对抗VEGF治疗反应不同。
- 作者认为结合这些细胞因子与血管生成的已知关联,其可能成为未来研究的潜在治疗靶点。
研究设计与样本
- 研究纳入干性AMD 13例、nAMD 196例、DME 21例、RVO 10例以及伴有白内障的正常对照34例。
- 采用免疫分析法检测房水中SCF、c-KIT、GAL-1和VEGF-A水平,按疾病分组及治疗反应进行分析。
主要发现
- nAMD组房水SCF、c-KIT和GAL-1分别为2.67±3.66、296.84±359.56和3945.61±5976.2 pg/mL,对照组分别为1.13±0.24、60.00±0.00和613.27±1595.12 pg/mL。
- DME组房水SCF、c-KIT和GAL-1分别为1.64±0.89、238.80±265.54和3701.23±4340.54 pg/mL。
- RVO组房水SCF、c-KIT和GAL-1分别为4.62±8.76、509.63±647.58和9079.60±11909.20 pg/mL。
- nAMD眼中SCF、c-KIT和GAL-1水平均与VEGF-A水平呈正相关。
- 抗VEGF玻璃体腔注射后GAL-1和VEGF-A水平显著下降,SCF和c-KIT无显著变化;治疗后视力改善的nAMD眼基线c-KIT、GAL-1和VEGF-A水平显著较低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the intraocular concentration profiles of stem cell factor (SCF)/c-KIT, galectin-1 (GAL-1), and vascular endothelial growth factor (VEGF)-A with regard to retinal disease and treatment response. METHODS: The study group included 13 patients with dry age-related macular degeneration (AMD), 196 with neovascular AMD (nAMD), 21 with diabetic macular edema (DME), 10 with retinal vein occlusion (RVO), and 34 normal subjects with cataracts. Aqueous humor levels of SCF, c-KIT, GAL-1, and VEGF-A were analyzed by immunoassay according to disease group and treatment response. RESULTS: Increased aqueous levels of SCF, c-KIT, and GAL-1 were observed in eyes with nAMD (2.67 ± 3.66, 296.84 ± 359.56, and 3945.61 ± 5976.2 pg/mL, respectively), DME (1.64 ± 0.89, 238.80 ± 265.54, and 3701.23 ± 4340.54 pg/mL, respectively), and RVO (4.62 ± 8.76, 509.63 ± 647.58, and 9079.60 ± 11909.20 pg/mL, respectively) compared with controls (1.13 ± 0.24, 60.00 ± 0.00, and 613.27 ± 1595.12 pg/mL, respectively). In the eyes of nAMD, the levels of all three cytokines correlated positively with VEGF-A levels. After intravitreal injections of anti-VEGF agents, the levels of GAL-1 and VEGF-A decreased significantly, whereas those of SCF and c-Kit showed no significant change. Eyes of nAMD patients with improved vision after treatment had significantly lower levels of c-KIT, GAL-1, and VEGF-A at baseline. CONCLUSIONS: The intraocular levels of cytokines were significantly elevated in eyes with nAMD, DME, and RVO compared to the controls and they showed different response to anti-VEGF treatment. With this result and their known association with angiogenesis, these cytokines may be potential therapeutic targets for future research.
引用
- Choi YJ, Kim HM, Na TY, et al. Intraocular Concentration of Stem Cell Factor/c-KIT and Galectin-1 in Retinal Diseases. Invest Ophthalmol Vis Sci. 2024. PMID: 39240551. doi:10.1167/iovs.65.11.11
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。